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Figure	1.	Representative	left	atrial	voltage	map.	Areas	in	red	represent	voltage	of	0.2-
0.5mV.	Pulmonary	veins	and	left	atrial	appendage	were	removed	prior	to	analysis.	
	
Figure	2.	Individual	value	plots	of	biomarker	levels	at	each	sample	site,	with	median	values.	Arrows	
on	ICTP	plot	represent	results	of	post-hoc	testing	of	between-group	differences.	
